Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-006637
Filing Date
2025-11-13
Accepted
2025-11-13 12:14:47
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 13303
2 d12039484_ex99-a.htm EX-99 7275
  Complete submission text file 0000919574-25-006637.txt   22208
Mailing Address 3 WEST HILL PLACE BOSTON MA 02110
Business Address 3 WEST HILL PLACE BOSTON MA 02110 6178568995
MANCHESTER MANAGEMENT CO LLC (Filed by) CIK: 0001169253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4
Business Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4 250-590-3968
EUPRAXIA PHARMACEUTICALS INC. (Subject) CIK: 0001581178 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94690 | Film No.: 251476627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)